0001842952-24-000017.txt : 20240322
0001842952-24-000017.hdr.sgml : 20240322
20240322080108
ACCESSION NUMBER: 0001842952-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240321
FILED AS OF DATE: 20240322
DATE AS OF CHANGE: 20240322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lehr Martin A.
CENTRAL INDEX KEY: 0001861989
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40654
FILM NUMBER: 24773132
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
STREET 2: SUITE 200
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Context Therapeutics Inc.
CENTRAL INDEX KEY: 0001842952
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 863738787
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 267-225-7416
MAIL ADDRESS:
STREET 1: 2001 MARKET STREET
STREET 2: SUITE 3915 UNIT #15
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: Context Therapeutics LLC
DATE OF NAME CHANGE: 20210128
4
1
wk-form4_1711108859.xml
FORM 4
X0508
4
2024-03-21
0
0001842952
Context Therapeutics Inc.
CNTX
0001861989
Lehr Martin A.
2001 MARKET STREET
SUITE 3915, UNIT #15
PHILADELPHIA
PA
19103
1
1
0
0
Chief Executive Officer
0
Stock Option (right to buy)
1.07
2024-03-21
4
A
0
291402
0
A
2034-03-20
Common Stock
291402
291402
D
The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
/s/ Alex Levit, Attorney-in-Fact
2024-03-22